1119020-07-3

Basic information

• Product Name: 4-[(S)-1-(tetrahydrofuran-2-yl)methoxy]benzoic acid methyl ester
• Synonyms: 4-[(S)-1-(tetrahydrofuran-2-yl)methoxy]benzoic acid methyl ester
• CAS NO: 1119020-07-3
• Molecular Weight: 236.268
• Mol File: 1119020-07-3.mol

Chemical Properties

• CAS DataBase Reference: 4-[(S)-1-(tetrahydrofuran-2-yl)methoxy]benzoic acid methyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: 4-[(S)-1-(tetrahydrofuran-2-yl)methoxy]benzoic acid methyl ester(1119020-07-3)
• EPA Substance Registry System: 4-[(S)-1-(tetrahydrofuran-2-yl)methoxy]benzoic acid methyl ester(1119020-07-3)

Safety Data

• Hazardous Substances Data: 1119020-07-3(Hazardous Substances Data)

Upstream product

• 137211-71-3 (S)-(tetrahydrofuran-2-yl)methyl methanesulfonate 
• 99-76-3 methyl 4-hydroxylbenzoate 
• 87392-07-2 (S)-tetrahydro-2-furoic acid 
• 97-99-4 (S)-(tetrahydrofuran-2-yl)methanol 
• 87324-01-4 (S)-(+)-methyl tetrahydrofuran-2-carboxylate 

Downstream Products

• 1119020-05-1 4-[(S)-1-(Tetrahydrofuran-2-yl)methoxy]benzoic acid 
• 1236404-04-8 N-[8-methyl-3-({[(2R)-tetrahydrofuran-2-ylmethyl]amino}methyl)quinolin-7-yl]-4-[(2S)-tetrahydrofuran-2-ylmethoxy]benzamide 
• 1236404-07-1 N-(3-{[(2-hydroxy-2-methylpropyl)amino]methyl}-8-methylquinolin-7-yl)-4-[(2S)-tetrahydrofuran-2-ylmethoxy]benzamide 
• 1236404-08-2 N-[8-methyl-3-({[(2s)-tetrahydrofuran-2-ylmethyl]amino}methyl)quinolin-7-yl]-4-[(2S)-tetrahydrofuran-2-ylmethoxy]benzamide 
• 1236404-12-8 N-{8-methyl-3-[(tetrahydro-2H-pyran-4-ylamino)methyl]quinolin-7-yl}-4-[(2S)-tetrahydrofuran-2-ylmethoxy]benzamide 
• 1236404-20-8 N-[8-methyl-3-({[(3-methyloxetan-3-yl)methyl]amino}methyl)quinolin-7-yl]-4-[(2S)-tetrahydrofuran-2-ylmethoxy]benzamide 
• 1236404-22-0 N-{3-[(ethylamino)methyl]-8-methylquinolin-7-yl}-4-[(2S)-tetrahydrofuran-2-ylmethoxy]benzamide 
• 1236404-23-1 N-{3-[(cyclopentylamino)methyl]-8-methylquinolin-7-yl}-4-[(2S)-tetrahydrofuran-2-ylmethoxy]benzamide 
• 1236404-25-3 N-(3-{[(cyclopropylmethyl)amino]methyl}-8-methylquinolin-7-yl)-4-[(2S)-tetrahydrofuran-2-ylmethoxy]benzamide 
• 1236404-27-5 N-(8-methyl-3-{[(2-methylpropyl)amino]methyl}quinolin-7-yl)-4-[(2S)-tetrahydrofuran-2-ylmethoxy]benzamide 
• 1236404-31-1 N-(3-{[(2,2-dimethylpropyl)amino]methyl}-8-methylquinolin-7-yl)-4-[(2S)-tetrahydrofuran-2-ylmethoxy]benzamide 
• 1236404-45-7 N-{8-methyl-3-[(propylamino)methyl]quinolin-7-yl}-4-[(2S)-tetrahydrofuran-2-ylmethoxy]benzamide 
• 1236404-48-0 N-[3-({[(1R,2R)-2-hydroxycyclohexyl]amino}methyl)-8-methylquinolin-7-yl]-4-[(2S)-tetrahydrofuran-2-ylmethoxy]benzamide 
• 1236404-50-4 N-[3-({[(1S,2S)-2-hydroxycyclohexyl]amino}methyl)-8-methylquinolin-7-yl]-4-[(2S)-tetrahydrofuran-2-ylmethoxy]benzamide 

Relevant articles and documents

QUINOLINE DERIVATIVE

The present invention provides a compound having a melanin-concentrating hormone receptor antagonistic action and low toxicity, which is useful as an agent for the prophylaxis or treatment of obesity and the like. The present invention relates to a compound represented by the formula (I): wherein each symbol is as defined in the specification, or a salt thereof.

NOVEL SUBSTITUTED TETRAHYDRONAPHTHALENES, PROCESS FOR THE PREPARATION THEREOF AND THE USE THEREOF AS MEDICAMENTS

The invention relates to substituted tetrahydronaphthalenes and derivatives thereof, and also to the physiologically compatible salts and physiologically functional derivatives thereof, to preparation thereof, to medicaments comprising at least one inventive substituted tetrahydronaphthalene or derivative thereof, and to the use of the inventive substituted tetrahydronaphthalenes and derivatives thereof as medicaments.